Some HSD17B13 variants such as the rs72613567 T > A have been associated with a protective effect in cirrhotic and HCC patients (127) as well as in European patients with ALD (128, 129) and HCV patients (130). This evidence concerns the gene HSD17B13 and hepatocellular carcinoma.